Systemic hypoxia, acute respiratory distress, pneumonia, sepsis, inflammatory responses, cytokine storm, and metabolic distress due to COVID-19 could also cause increased insulin resistance and metabolic decompensation acutely [19,20,21,22,23,24,25], which could lead to worse T2D disease progression and new diabetes-related complications. This evidence concerns the gene INS and COVID-19.